Skip to content
Screener

MaxLinear MXL Business Segments — Net loss

Similar metrics at other companies

Veradermics logo
MANEReportable Segment — Net loss
-$27.23M-120%
Zscaler logo
ZSReportable Segment — Net loss
-$13.88M-237%
Biohaven logo
BHVNReportable Segment — Net loss
-$130.53M+41.1%
Bicara Therapeutics logo
BCAXReportable Segment — Net loss
-$56.21M-52.6%
YSS
YSSReportable Segment — Net loss
-$114.84M-879%
Vaxcyte, Inc. logo
PCVXReportable Segment — Net loss
-$320.62M-128%

Other financials

Income statement

See full
Revenue$168.8M+55.2%
Gross profit$97.7M+58.7%
Operating income-$4.2M+83.0%
Net income$1.8M+107%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$64.8M-40.3%
Total debt$148.2M+0.4%
Total equity$484.8M-0.7%
Total assets$822.6M-4.8%

Cash flow

See full
Operating cash flow-$8.9M+22.2%
CapEx$2.3M+99.5%
Free cash flow-$10.3M+23.4%

Valuation

See full
Market cap$6.12B+362%
Enterprise value$6.2B+355%
P/S10.8×+7.2×

Profitability

See full
Gross margin57.5%+1.7pp
Operating margin-13.6%-5.7pp
Net margin-18.2%-7.3pp
FCF margin2%+1.0pp

Returns & leverage

See full
Return on equity-21.3%-6.5pp
Debt / equity0.3×0.0×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by MaxLinear in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: MaxLinear’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001288469-26-000051
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total other income (expense), net(2,365)(6,086)(3,808)(8,994)
Loss before income taxes(6,550)(30,701)(25,202)(79,703)
Income tax provision (benefit)(8,310)(4,115)18,175(3,404)
Net income (loss)$1,760$(26,586)$(43,377)$(76,299)
Net income (loss) per share:
Basic$0.02$(0.31)$(0.49)$(0.89)
Diluted$0.02$(0.31)$(0.49)$(0.89)
Shares used to compute net income (loss) per share:

Item 1. Financial Statements (unaudited)

FAQ

What is MaxLinear's business segments — net loss?
MaxLinear (MXL) reported business segments — net loss of $1.76M in Q2 2026.
How has MaxLinear's business segments — net loss changed year-over-year?
MaxLinear's business segments — net loss increased by 106.6% year-over-year, from -$26.59M to $1.76M.
What is the long-term trend for MaxLinear's business segments — net loss?
Over 3 years (2022 to 2025), MaxLinear's business segments — net loss has grown at a 3.0% compound annual growth rate (CAGR), from $125.04M to -$136.68M.
What does business segments — net loss mean?
This represents the bottom-line financial result for the specific business segment after deducting all operating expenses, interest, taxes, and other charges from segment revenue. A net loss indicates that the costs associated with the segment's activities exceeded the revenue generated during the period. It serves as a primary indicator of the segment's current profitability and operational efficiency.

Ask your AI about MaxLinear's business segments — net loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude